169 related articles for article (PubMed ID: 35000717)
1. A 67-Year-Old Male Patient With COVID-19 With Worsening Respiratory Function and Acute Kidney Failure.
Melchers M; Festen B; den Dekker BM; Mooren ERM; van Binsbergen AL; van Bree SHW; Heusinkveld M; Schellaars R; Buil JB; Verweij PE; van Zanten ARH
Chest; 2022 Jan; 161(1):e5-e11. PubMed ID: 35000717
[TBL] [Abstract][Full Text] [Related]
2. Invasive pulmonary aspergillosis associated with COVID-19 in a kidney transplant recipient.
Trujillo H; Fernández-Ruiz M; Gutiérrez E; Sevillano Á; Caravaca-Fontán F; Morales E; López-Medrano F; Aguado JM; Praga M; Andrés A
Transpl Infect Dis; 2021 Apr; 23(2):e13501. PubMed ID: 33185971
[TBL] [Abstract][Full Text] [Related]
3. Invasive pulmonary mucormycosis: rare presentation with pulmonary eosinophilia.
Hirano T; Yamada M; Sato K; Murakami K; Tamai T; Mitsuhashi Y; Tamada T; Sugiura H; Sato N; Saito R; Tominaga J; Watanabe A; Ichinose M
BMC Pulm Med; 2017 Apr; 17(1):76. PubMed ID: 28454572
[TBL] [Abstract][Full Text] [Related]
4. Airway Obstruction Due to Invasive Tracheobronchial Aspergillosis.
Zheng X; Shao J; Xu J
Am J Med Sci; 2016 Aug; 352(2):218. PubMed ID: 27524222
[No Abstract] [Full Text] [Related]
5. COVID-19-associated pulmonary aspergillosis in a Japanese man: A case report.
Imoto W; Himura H; Matsuo K; Kawata S; Kiritoshi A; Deguchi R; Miyashita M; Kaga S; Noda T; Yamamoto K; Yamada K; Uchida K; Nishimura T; Yamamoto H; Mizobata Y; Kakeya H
J Infect Chemother; 2021 Jun; 27(6):911-914. PubMed ID: 33674201
[TBL] [Abstract][Full Text] [Related]
6. [Expert consensus on diagnosis and treatment of severe COVID-19 associated pulmonary
;
Zhonghua Jie He He Hu Xi Za Zhi; 2024 Jan; 47(1):10-23. PubMed ID: 38062689
[TBL] [Abstract][Full Text] [Related]
7. Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance.
Koehler P; Bassetti M; Chakrabarti A; Chen SCA; Colombo AL; Hoenigl M; Klimko N; Lass-Flörl C; Oladele RO; Vinh DC; Zhu LP; Böll B; Brüggemann R; Gangneux JP; Perfect JR; Patterson TF; Persigehl T; Meis JF; Ostrosky-Zeichner L; White PL; Verweij PE; Cornely OA; ; ; ; ; ; ; ; ; ; ; ; ; ;
Lancet Infect Dis; 2021 Jun; 21(6):e149-e162. PubMed ID: 33333012
[TBL] [Abstract][Full Text] [Related]
8. An overview of the available treatments for chronic cavitary pulmonary aspergillosis.
Sehgal IS; Dhooria S; Muthu V; Prasad KT; Agarwal R
Expert Rev Respir Med; 2020 Jul; 14(7):715-727. PubMed ID: 32249630
[TBL] [Abstract][Full Text] [Related]
9. Successful outcome of disseminated mucormycosis in a 3-year-old child suffering from acute leukaemia: the role of isavuconazole? A case report.
Cornu M; Bruno B; Loridant S; Navarin P; François N; Lanternier F; Amzallag-Bellenger E; Dubos F; Mazingue F; Sendid B
BMC Pharmacol Toxicol; 2018 Dec; 19(1):81. PubMed ID: 30522521
[TBL] [Abstract][Full Text] [Related]
10. Invasive mould infections in the ICU setting: complexities and solutions.
Bassetti M; Bouza E
J Antimicrob Chemother; 2017 Mar; 72(suppl_1):i39-i47. PubMed ID: 28355466
[TBL] [Abstract][Full Text] [Related]
11. A unique case of upper GI bleed.
Bansal R; Duddempudi S; Thelmo W; Rajnish L
Acta Gastroenterol Belg; 2017; 80(4):553-554. PubMed ID: 29560659
[No Abstract] [Full Text] [Related]
12. Simultaneous mold infections in an orthotopic heart transplant recipient.
Clauss H; Samuel R
Transpl Infect Dis; 2008 Oct; 10(5):343-5. PubMed ID: 18194369
[TBL] [Abstract][Full Text] [Related]
13. Graded isavuconazole introduction in a patient with voriconazole allergy.
Morales MK; Harris C; Shoham S
Transpl Infect Dis; 2017 Dec; 19(6):. PubMed ID: 28851131
[TBL] [Abstract][Full Text] [Related]
14. Mixed mold infection with
Bellanger AP; Navellou JC; Lepiller Q; Brion A; Brunel AS; Millon L; Berceanu A
Infect Dis Now; 2021 Oct; 51(7):633-635. PubMed ID: 33527098
[No Abstract] [Full Text] [Related]
15. Invasive Fungal Disease, Isavuconazole Treatment Failure, and Death in Acute Myeloid Leukemia Patients.
Bellanger AP; Berceanu A; Scherer E; Desbrosses Y; Daguindau E; Rocchi S; Millon L
Emerg Infect Dis; 2019 Sep; 25(9):1778-1779. PubMed ID: 31441760
[TBL] [Abstract][Full Text] [Related]
16. Disseminated Mucormycosis With Cerebral Involvement Owing to Rhizopus Microsporus in a Kidney Recipient Treated With Combined Liposomal Amphotericin B and Posaconazole Therapy.
Ville S; Talarmin JP; Gaultier-Lintia A; Bouquié R; Sagan C; Le Pape P; Giral M; Morio F
Exp Clin Transplant; 2016 Feb; 14(1):96-9. PubMed ID: 25275881
[TBL] [Abstract][Full Text] [Related]
17. A 56-year-old man with undifferentiated fever in the ICU and endobronchial plaques.
Del Rosario RC; Halloush RA; Khasawneh FA
Chest; 2013 Feb; 143(2):566-569. PubMed ID: 23381323
[No Abstract] [Full Text] [Related]
18. New pharmacological opportunities for the treatment of invasive mould diseases.
Ledoux MP; Toussaint E; Denis J; Herbrecht R
J Antimicrob Chemother; 2017 Mar; 72(suppl_1):i48-i58. PubMed ID: 28355467
[TBL] [Abstract][Full Text] [Related]
19. Cutaneous mucormycosis.
Vulsteke JB; Deeren D
Transpl Infect Dis; 2019 Apr; 21(2):e13039. PubMed ID: 30548761
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness analysis of isavuconazole versus voriconazole for the treatment of patients with possible invasive aspergillosis in Sweden.
Floros L; Kuessner D; Posthumus J; Bagshaw E; Sjölin J
BMC Infect Dis; 2019 Feb; 19(1):134. PubMed ID: 30744563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
